A Single Center Open-label, Randomized, Single-dose, 3-way Crossover Study to Compare the Safety, Tolerability, and Pharmacokinetics of Lacosamide Administered as Oral Tablet or Intravenous Infusion in Healthy Japanese Subjects

Trial Profile

A Single Center Open-label, Randomized, Single-dose, 3-way Crossover Study to Compare the Safety, Tolerability, and Pharmacokinetics of Lacosamide Administered as Oral Tablet or Intravenous Infusion in Healthy Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2014

At a glance

  • Drugs Lacosamide (Primary) ; Lacosamide (Primary)
  • Indications Fibromyalgia; Osteoarthritis; Partial epilepsies; Sleep disorders; Tonic-clonic epilepsy
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma SA
  • Most Recent Events

    • 03 Nov 2014 Last checked against ClinicalTrials.gov record.
    • 08 Jan 2014 Status changed to completed as reported by ClinicalTrials.gov record.
    • 24 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top